Patient Registry of Intrathecal Ziconotide Management(PRIZM)

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Confirmatory Clinical Study of Oxiplex

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement